Sonova (OTCMKTS:SONVY) Stock Crosses Above 50-Day Moving Average – Here’s What Happened

Sonova Holding (OTCMKTS:SONVYGet Free Report) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $51.11 and traded as high as $57.92. Sonova shares last traded at $57.37, with a volume of 5,453 shares changing hands.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on SONVY shares. Morgan Stanley raised shares of Sonova from an “underweight” rating to an “equal weight” rating in a research report on Tuesday, June 23rd. UBS Group raised Sonova from a “hold” rating to a “buy” rating in a report on Wednesday, July 22nd. Finally, Citigroup reiterated a “sell” rating on shares of Sonova in a research report on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

View Our Latest Report on Sonova

Sonova Price Performance

The stock has a 50 day simple moving average of $51.11 and a two-hundred day simple moving average of $49.80. The company has a quick ratio of 1.43, a current ratio of 1.75 and a debt-to-equity ratio of 0.51.

About Sonova

(Get Free Report)

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

Further Reading

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.